Pfizer and BioNTech Receive US FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older

Pfizer, Inc. and BioNTech SE announced that the FDA has expanded the Emergency Use Authorization of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 16 years of age and older.